Vermont Tepezza Lawsuit Attorney

Tepezza, an injectable drug used during thyroid eye disease treatment, was approved by the FDA in January 2020 and has since been administered to thousands of patients. However, numerous Vermont Tepezza lawsuits have been filed against Horizon Therapeutics, the company responsible for developing and marketing the drug.

These Tepezza hearing loss lawsuits claim that Tepezza causes permanent hearing damage and tinnitus in patients and that Horizon failed to provide adequate warnings about these risks.

If you or a loved one has experienced Tepezza-related hearing loss, Schmidt & Clark, LLP is here to assist. As a national law firm specializing in plaintiffs’ cases, we are committed to securing the justice and compensation you deserve.

Vermont Tepezza Lawsuits

As mentioned earlier, a growing number of Tepezza hearing loss lawsuits are being filed against Horizon Therapeutics, alleging that the drug has caused permanent hearing loss and tinnitus in patients. While Tepezza was designed to treat thyroid eye disease, these plaintiffs claim that they have experienced life-altering hearing issues as a result of the medication.

Keep in mind, that these claims are currently under investigation and haven’t been proven in court yet. With the number of lawsuits growing and the seriousness of allegations, staying updated about the latest developments in this legal battle is necessary for Tepezza users and their families.

Plaintiffs’ Claims and Horizon’s Defense

The plaintiffs in these Tepezza lawsuits argue that Horizon failed to adequately warn patients and doctors of the risks of hearing loss and tinnitus associated with the drug.

They claim that even though numerous studies and patient reports have established a link between Tepezza and hearing loss, the manufacturer did not provide sufficient information to users and healthcare professionals.

On the other hand, Horizon has defended its actions by stating that it had disclosed the potential side effects, including hearing loss, on the drug’s label. The company argues that the risks are reversible and that they have complied with FDA regulations, obtaining FDA approval.

However, the outcome of these lawsuits remains uncertain as both parties present their evidence and arguments in court.

What Is Tepezza?

Tepezza is an injectable drug developed by Horizon Therapeutics and approved by the FDA in January 2020 [1]. It is designed to treat thyroid eye disease (TED), also known as Graves’ eye disease, an autoimmune condition that causes inflammation and swelling around the eyes, often affecting women more than men.

Tepezza works by binding to receptor switches behind the eyes, blocking the swelling of muscle and fat tissue associated with TED.

Tepezza Side Effects & Hearing Loss

While Tepezza has been effective in treating thyroid eye disease for many patients, it has also been linked to some serious side effects, including hearing loss and tinnitus. The hearing issues reported by patients include ringing in the ears, autophony (hearing one’s own voice unusually loud), and a feeling of the ears being plugged.

In some cases, the hearing loss caused by Tepezza has been permanent and irreversible, leaving patients with a significantly reduced quality of life. This has led to the filing of numerous lawsuits against Horizon Therapeutics, with plaintiffs seeking compensation for their injuries and alleging that the company failed to provide adequate warnings about the potential risks associated with Tepezza.

Does Tepezza Cause Hearing Problems?

Tepezza does cause hearing problems. Research and case reports suggest a link between Tepezza and hearing loss or tinnitus [2].

In two clinical trials conducted prior to FDA approval of the drug, otologic symptoms were reported in 10 percent of patients. The new study found the rate could be as high as 65 percent. – The Endocrine Society

Many patients have reported symptoms such as ringing in the ears, autophony, and a feeling of the ears being plugged, which can significantly impact their daily lives and overall well-being. Hearing loss caused by Tepezza has been a major issue. In some cases, the damage sustained is even more severe, with it being permanent and irreversible.

Healthcare professionals need to be mindful of these possible hearing-related side effects and closely monitor patients who are taking Tepezza.

Researchers have recommended that doctors conduct baseline audiogram testing and screen new patients for hearing problems before starting the treatment. This will help ensure that any potential hearing issues are detected and addressed early on, minimizing the risk of permanent damage.

Potential Settlements and Compensation in Vermont Tepezza Lawsuits

Plaintiffs in Vermont Tepezza lawsuits may be eligible for compensation if they can prove that their temporary hearing loss or tinnitus, which could be considered as hearing damage, was caused by the drug.

Compensation can come in the form of a settlement, jury award, or court-ordered judgment, and may cover medical bills, pain and suffering, lost wages, and decreased quality of life due to sensorineural hearing loss.

A Tepezza lawsuit settlement can range from $140,000 to $350,000, depending on the specific circumstances of each case.

Factors Influencing Settlement Amounts

Several factors can influence the settlement amounts in Tepezza lawsuits. One of the most significant factors is the severity of the patient’s injury. Generally, the more serious the injury, the higher the potential settlement amount.

For example, a patient who has experienced permanent and irreversible hearing loss may be able to receive a larger settlement than someone who has experienced temporary and reversible hearing issues.

Another important factor in determining settlement amounts is the impact of the injury on the plaintiff’s life. If the hearing loss or tinnitus, also known as hearing impairment, has caused a major disruption in the plaintiff’s life, such as a loss of income or the inability to work, the settlement amount may be higher.

Additionally, the strength of the plaintiff’s case and the evidence they can provide to support their claim will also play a crucial role in determining the final settlement amount.

Who Qualifies to File a Vermont Tepezza Lawsuit?

Individuals who have experienced hearing loss or tinnitus after taking Tepezza qualify to file a Vermont Tepezza lawsuit against Horizon Therapeutics.

To be eligible, the plaintiff must demonstrate that their hearing issues were caused by the drug and provide evidence to support their claim, such as medical records and doctor’s notes.

If you or a loved one may qualify to file a lawsuit, seeking advice from a seasoned attorney to discuss your options and safeguard your rights is advisable.

Filing a Vermont Tepezza Hearing Loss Lawsuit

Should you meet the eligibility criteria and decide on filing a Vermont Tepezza hearing loss lawsuit, engaging a proficient attorney who can guide you through the legal process is vital. An experienced lawyer will help you gather the necessary evidence, build a strong case, and ensure that your claim is filed within the statute of limitations for your state.

Collaborating with a competent legal team can enhance your chances of obtaining the rightful compensation for your Tepezza-induced hearing problems.

Eligibility Criteria

To be eligible to file a Tepezza hearing loss lawsuit, you must have experienced hearing loss or tinnitus after taking the drug and have evidence to support your claim. This can include medical records, doctor’s notes, and other documentation that demonstrates a link between your hearing issues and Tepezza usage.

If these criteria are met and you are contemplating filing a lawsuit, seeking advice from a seasoned attorney who can offer guidance and support throughout the legal process is recommended.

Statute of Limitations

The statute of limitations for filing tepezza lawsuits varies by state, so it is important to consult with a Tepezza attorney to ensure timely filing. If you believe you have a case, it’s crucial to file a Tepezza lawsuit within the appropriate time frame to avoid dismissal and secure compensation for your injuries.

FAQs

Is there a time limit for filing a Tepezza lawsuit in Vermont?
Yes, statutes of limitations apply and vary by state. In Vermont, it’s important to consult with a lawyer promptly to avoid missing the deadline.

What should I do if I experience side effects from Tepezza?
Seek immediate medical attention and consult a healthcare professional. Document your symptoms and consider consulting a lawyer to discuss your legal options.

Are there any class-action lawsuits for Tepezza?
Yes, there may be ongoing class-action lawsuits that consolidate individual claims to streamline the legal process and increase the chances of a favorable outcome.

Can I join a Tepezza lawsuit if I used it years ago?
Yes, you may still be eligible to file a lawsuit depending on the statute of limitations and your diagnosis timeline. Consult a lawyer to evaluate your case.

See all related dangerous drugs lawsuits our attorneys covered so far.

Get Your Free Case Evaluation From Vermont Tepezza Lawyers

At Schmidt and Clark, LLP we stand by your side in your time of need. If you or a loved one developed permanent hearing loss or persistent subjective hearing loss related to Tepezza, please reach out to us without hesitation. Our team holds extensive experience in handling such cases and will provide full support throughout the entire process.

You deserve to be informed about your legal rights and the potential eligibility for a lawsuit. Be assured that our consultations are always offered at no cost, and you won’t face any financial obligations unless we secure a favorable outcome for your case. Our commitment is to serve you with the same empathy and dedication we would provide to our own families.

Connect with Schmidt and Clark today for a comprehensive case evaluation. Let us be your trusted partner on this legal journey.

Reference:

1. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trial-snapshot-tepezza
2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089925/